On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a ...

On Friday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.32 which represents a decrease of $-0.04 or -11.11% from the prior close of $0.36. The stock opened at $0.37 and touched a ...

(BLUE) stock downgraded by Bank of America and J.P. Morgan after the company's Q3 2024 results. Read more here.

In celebration of its 100th year as an institution open to the public, the Morgan Library and Museum has launched the ...

On Thursday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.36 which represents a decrease of $-0.02 or -5.26% from the prior close of $0.38. The stock opened at $0.37 and touched a ...

Analyst Eric Joseph of J.P. Morgan maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price target of ...

J.P. Morgan analyst Eric Joseph maintained a Sell rating on Novavax ... Joseph covers the Healthcare sector, focusing on stocks such as Bluebird Bio, Wave Life Sciences, and Novavax. TipRanks tracks ...

JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

JPMorgan Chase & Co. cut shares of bluebird bio (NASDAQ:BLUE – Free Report) from a neutral rating to an underweight rating in ...

(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...